Iga Swiatek accepts one-month ban after testing positive for trimetazidine
- World No 2 deemed her level of fault ‘at the lowest end’
- Pole’s medication for jet lag and sleep was contaminated
Iga Swiatek, the world No 2 women’s tennis player, has received a one month ban after testing positive for the banned substance trimetazidine (TMZ) in August 2024.
In a statement on Thursday, the International Tennis Integrity Agency, which governs the tennis anti-doping programme, ruled that Swiatek’s anti-doping rule violation was not intentional and that she bore no significant fault or negligence for the positive test on “the lowest end of the range” and they imposed a one month ban.